During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

A new study published in Nature Cancer reveals that age-related metabolic decline impairs the efficacy of CAR-T cell therapy.

Personalized medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most promising tools.

Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

In biology classes from high school through university, I learned that mitochondria are little objects that reside within ...